PODD

SELL

Insulet Corporation

Healthcare · Rank #185 · Analyzed Apr 20, 2026

$203.73

Current Price

$31.29

Intrinsic Value

-82.5%

Upside/Downside

3/10

Score

3/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score3/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 82.5%

Fair Value Range

Low$17.50

Base (IV)$31.29

High$35.70

Entry Points

Conservative$17.50

Moderate$24.39

Aggressive$31.29

Quality & Moat Breakdown

Return on Equity18.1% → 1.0/1.0

Debt LevelD/E 66 → 0/1.0

Revenue QualityGrowth 22.7%, margin Δ+21.5% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins9.1% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.